BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/6/2020 2:43:56 PM | Browse: 102 | Download: 57
Publication Name World Journal of Gastroenterology
Manuscript ID 53658
Country/Territory Japan
Received
2019-12-27 11:06
Peer-Review Started
2019-12-27 11:12
To Make the First Decision
Return for Revision
2020-02-14 17:43
Revised
2020-03-27 11:36
Second Decision
2020-05-22 09:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-05-23 01:04
Articles in Press
2020-05-23 01:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-06-04 07:44
Publish the Manuscript Online
2020-06-06 14:43
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Review
Article Title Vaccine therapy for dysbiosis-related diseases
Manuscript Source Invited Manuscript
All Author List Kosuke Fujimoto and Satoshi Uematsu
ORCID
Author(s) ORCID Number
Kosuke Fujimoto http://orcid.org/0000-0002-2948-549X
Satoshi Uematsu http://orcid.org/0000-0002-5347-6737
Funding Agency and Grant Number
Funding Agency Grant Number
Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-Aid for Early-Career Scientists) 19K17932
Corresponding author Satoshi Uematsu, MD, PhD, Professor, Department of Immunology and Genomics, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. uematsu.satoshi@med.osaka-cu.ac.jp
Key Words Dysbiosis; IgA; Microbiome; Mucosal immunity; Pathobiont; Vaccine
Core Tip How to control intestinal pathogenic bacteria that mediate multifactorial diseases is a major concern worldwide. There are few methods for controlling only intestinal pathogenic bacteria; therefore, we have developed a prime–boost type, next-generation mucosal vaccine, and have used it for control of bacterial intestinal diseases. This vaccine can contribute to prevention of Clostridium ramosum-mediated obesity. Thus, this approach might be useful for protecting against microbe-associated disorders of the intestine.
Publish Date 2020-06-06 14:43
Citation Fujimoto K, Uematsu S. Vaccine therapy for dysbiosis-related diseases. World J Gastroenterol 2020; 26(21): 2758-2767
Url https://www.wjgnet.com/1007-9327/full/v26/i21/2758.htm
DOI https://dx.doi.org/10.3748/wjg.v26.i21.2758
Full Article (PDF) WJG-26-2758.pdf
Full Article (Word) WJG-26-2758.docx
Manuscript File 53658-Review.docx
Answering Reviewers 53658-Answering reviewers.pdf
Audio Core Tip 53658-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 53658-Conflict-of-interest statement.pdf
Copyright License Agreement 53658-Copyright license agreement.PDF
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 53658-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 53658-Language certificate.pdf
Peer-review Report 53658-Peer-review(s).pdf
Scientific Misconduct Check 53658-Scientific misconduct check.pdf
Scientific Editor Work List 53658-Scientific editor work list.pdf